The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Diclofenac Potassium · DICLOFENAC POTASSIUM 25 mg/1 · Capsule, Liquid Filled · Oral · Aurobindo Pharma Limited
NDC 59651-0353-01 · 100 CAPSULE, LIQUID FILLED in 1 BOTTLE · ANDA · View full market →
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 00480-9435-89) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 3 quarters since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Assertio Therapeutics, Inc. | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Ontario Limited | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Leading Pharma, LLC | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lifsa Drugs LLC | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Softgels Inc. | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Bryant Ranch Prepack | DICLOFENAC POTASSIUM 25 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Diclofenac Potassium — NDC 59651-0353-01," retrieved September 3, 2026, https://drugdashboards.com/drug/59651035301.
Free to cite with attribution — see how the data is put together.